(19)

(11)

EP 4 739 315 A1

(12)

(43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 24748745.7 (22) Date of filing: 05.07.2024

(51) International Patent Classification (IPC):  A61K 31/519(2006.01) A61P 25/28(2006.01) A61P 35/02(2006.01) A61P 9/00(2006.01) A61P 29/00(2006.01) A61P 37/00(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/519; A61P 35/02; A61P 25/28; A61P 29/00; A61P 37/00; A61P 9/00 (86) International application number: PCT/US2024/036944 (87) International publication number: WO 2025/010421 (09.01.2025 Gazette 2025/02)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 06.07.2023 US 202363512188 P 06.06.2024 US 202463657018 P (71) Applicant: Halia Therapeutics, Inc. Lehi, UT 84043 (US)	(72) Inventors: BEARSS, David James Lehi, Utah 84043 (US) JANAT-AMSBURY, Margit Lehi, Utah 84043 (US) (74) Representative: HGF  HGF Limited 4th Floor, 1 City Square Leeds LS1 2ES Leeds LS1 2ES (GB)